Incidence and risk factors for severe thrombocytopenia in lymphoma patients receiving chemotherapy.

被引：0
|
作者：
Zhou, Xiao
Teegala, Shyam
Ji, Yuan
Fayad, Luis
Romaguera, Jorge Enrique
Hagemeister, F. B.
Vadhan-Raj, Saroj
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Biostat & Applied Math, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Canc Ctr, Div Pharma, Houston, TX 77030 USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3994
引用
收藏
页码：76B / 76B
页数：1
相关论文
共 50 条
  • [31] Incidence and Risk Factors of Thrombocytopenia in Patients Receiving Intermittent Antiretroviral Therapy: A Substudy of the ANRS 106-Window Trial
    Bouldouyre, Marie-Anne
    Charreau, Isabelle
    Marchou, Bruno
    Tangre, Philippe
    Katlama, Christine
    Morlat, Philippe
    Meiffredy, Vincent
    Vittecoq, Daniel
    Bierling, Philippe
    Aboulker, Jean-Pierre
    Molina, Jean-Michel
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 52 (05) : 531 - 537
  • [32] Detailed analysis of neutropenic risk factors in patients with prostate cancer treated with chemotherapy.
    Laber, ER
    Laber, DA
    BLOOD, 2004, 104 (11) : 37B - 37B
  • [33] Prospective validation of a risk model for first cycle neutropenic complications in patients receiving cancer chemotherapy.
    Lyman, G. H.
    Kuderer, N. M.
    Crawford, J.
    Wolff, D. A.
    Culakova, E.
    Poniewierski, M. S.
    Dale, D. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 483S - 483S
  • [34] Risk factors for hospitalization in elderly cancer patients receiving chemotherapy
    Kleiner, J. M.
    Culakova, E.
    Dale, D. C.
    Crawford, J.
    Poniewierski, M. S.
    Wolff, D. A.
    Lyman, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [35] INCIDENCE AND RISK FACTORS FOR HEPATITIS IN PATIENTS RECEIVING ANTITUBERCULAR TREATMENT
    Singh, Manish Kumar
    Mamatha, S.
    Jain, Rashee
    Jha, Amit Kumar
    Nigam, Sanjay Kumar
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2013, 2 (01): : 1 - 7
  • [36] Fatigue, pain, and functional status in patients receiving outpatient chemotherapy.
    Siefert, Mary Lou
    ONCOLOGY NURSING FORUM, 2007, 34 (01) : 181 - 181
  • [37] Economic analysis of prophylactic pegfilgrastim in cancer patients receiving chemotherapy.
    Eldar-Lissai, A
    Cosler, LE
    Lyman, GH
    BLOOD, 2004, 104 (11) : 608A - 608A
  • [38] Thromboembolism in multiple myeloma patients receiving thalidomide combination chemotherapy.
    Wrigh, A.
    Elkins, S.
    Files, J.
    Bigelow, C.
    Herrin, V.
    Sample, M.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (01) : S302 - S302
  • [39] Continuous monitoring of mobility performance trajectory in patients receiving chemotherapy.
    Yarlagadda, Sudha
    Najafi, Bijan
    Chu, Jinna
    Wang, Changhong
    Sada, Yvonne
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [40] Muscle weakness is a significant problem in older patients receiving chemotherapy.
    Extermann, M.
    Boler, I.
    O'Neill, E.
    Brown, R.
    Defelice, J.
    Levine, R.
    Lubiner, E.
    Reyes, P.
    Schreiber, F.
    Lyman, G. H.
    Balducci, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 479S - 479S
12345